Aveanna Healthcare (AVAH) Bank of America Home Care Conference summary
Event summary combining transcript, slides, and related documents.
Bank of America Home Care Conference summary
30 Jun, 2026Strategic initiatives and business model
Focus on scale and density across 38 states, serving over 80,000 patients with pediatric, adult, and geriatric care.
Recent acquisition of Thrive Skilled Pediatrics expanded pediatric services into Kansas and New Mexico and increased density in five other states.
Five key initiatives: enhancing payer partnerships, cost efficiencies, modernizing Medical Solutions, capital management, and employee engagement.
Preferred payer strategy now includes 93 agreements across all segments, with no single payer over 10% of revenue.
Value-based agreements and government affairs drive alignment and growth, with 10 state rate increases achieved in 2025.
Financial performance and outlook
Updated 2025 guidance: revenue above $2.375 billion and Adjusted EBITDA above $300 million.
Q3 revenue up 22.2% year-over-year to $622 million; EBITDA up 67.5% to $80.1 million.
Private Duty Services (PDS) segment grew 25.6% year-over-year; Home Health and Hospice up 15.3%.
Medical Solutions segment growth muted in 2025 due to modernization, expected to return to 8-10% growth after Q1.
Long-term organic growth targeted at 5-7%, with strategic M&A expected to push total growth above 10%.
Preferred payer and rate environment
PDS preferred payer agreements increased from 22 to 30 in 2025, with 56-60% of managed care PDS volumes now under these contracts.
New patient admissions in PDS are over 95% aligned with preferred payers; goal to reach low- to mid-80% in next 2-3 years.
Preferred payer contracts typically offer a 20% premium over standard fee schedules, enabling higher caregiver wages and improved staffing.
Gross margin in PDS remains stable, with additional rate dollars invested in wages.
State rate increases have largely caught up post-COVID, with future increases expected to be smaller and more targeted.
Latest events from Aveanna Healthcare
- Q1 2025 saw 14% revenue growth, 93% EBITDA rise, and raised full-year guidance.AVAH
Q1 20259 Jul 2026 - Q2 revenue rose 7% to $505M, adjusted EBITDA up 27.3%, guidance raised for 2024.AVAH
Q2 20249 Jul 2026 - Raised 2025 guidance and strong Q3 results highlight scalable, value-based growth and margin stability.AVAH
44th Annual J.P. Morgan Healthcare Conference8 Jul 2026 - Double-digit revenue and profit growth in 2025, robust 2026 outlook, and major acquisition announced.AVAH
Q4 20258 Jul 2026 - Accelerated growth and margin expansion driven by acquisitions, payer strategy, and financial discipline.AVAH
46th Annual William Blair Growth Stock Conference2 Jun 2026 - Q1 2026 revenue rose 15.9% and adjusted EBITDA 25.2%, driven by value-based homecare growth.AVAH
Investor presentation15 May 2026 - Q1 revenue and earnings surged, with raised guidance and a major pediatric care acquisition pending.AVAH
Q1 202614 May 2026 - Director elections, auditor ratification, and say-on-pay vote headline the annual meeting agenda.AVAH
Proxy filing17 Apr 2026 - Strong financial results, board elections, auditor ratification, and executive pay up for vote.AVAH
Proxy filing17 Apr 2026